After two years (120 weeks), the patients retained roughly one-third of their original weight loss (5.6% of the original 17.3% loss)
Nonetheless, individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) should discuss this with their clinician before enrolling in any trial involving this class of agent
According to the CDC, as of 2021, 38.1 million adults (14.7%) in the United States had diabetes, with the incidence increasing with age
This is a mixture of different medications that will have the same effect as a GLP-1 agonist
Editorial Advisory Board Member, Harvard Health Publishing Ozempic and other GLP-1 receptor agonists have gained attention for their role in treating type 2 diabetes and promoting weight loss
This breakfast works on multiple levels